Ranbaxy Laboratories Ltd has announced the following Unaudited results for the quarter ended June 30, 2010:
The Standalone results for the Quarter ended June 30, 2010
The Company has posted a net loss of Rs (0.77) million for the quarter ended June 30, 2010 as compared to net profit of Rs 6754.50 million for the quarter ended June 30, 2009. Total Income has increased from Rs 13123.81 million for the quarter ended June 30, 2009 to Rs 12344.93 million for the quarter ended June 30, 2010.
The Consolidated results for the Quarter ended June 30, 2010
The Group has posted a net profit after tax and minority interest of Rs 3257.14 million for the quarter ended June 30, 2010 as compared to Rs 6935.96 million for the quarter ended June 30, 2009. Total Income has increased from Rs 21099.55 million for the quarter ended June 30, 2009 to Rs 22777.03 million for the quarter ended June 30, 2010.
Source: BSE India (Corporate Announcements)
